Sharekhan's research report on Mastek
Mastek reported revenues of $92.6 million, up 4.4% q-o-q/13.5% y-o-y in constant currency (cc), in line with our estimates. Biz Analytica’s contribution for the quarter stood at $2.5 million, while organic growth stood at 2.3% in US Dollar terms and 2.7% in rupee terms. EBITDA margins fell sharply to 16.1%, down ~160 bps q-o-q missing our estimates of 16.9% due to wage hike(130-140bps impact) effective August this year and low margin profile of Biz Analytica (30-40 bps). The company is seeing consistent improvement in order booking and the same is reflected in the 12-month order backlog, which has grown by 5.6% q-o-q /22.3% y-o-y in rupee terms. The company added 29 new clients in Q2FY24. We believe the company’s strong UK public sector relationships, robust 12-month order backlog in addition to build-up of joint deals and pipeline aided by Biz Analytica acquisition positions the company to achieve stronger industry leading growth.
Outlook
Hence, we maintain Buy with a revised price target of Rs. 2,575 (increase in PT reflects roll forward to Sep FY25E EPS). At the CMP the stock trades at 19.5/15.4x its FY25/26E EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.